Calcium dobesilate reduces VEGF signaling by interfering with heparan sulfate binding site and protects from vascular complications in diabetic mice

Inhibiting vascular endothelial growth factor (VEGF) is a therapeutic option in diabetic microangiopathy. However, VEGF is needed at physiological concentrations to maintain glomerular integrity; complete VEGF blockade has deleterious effects on glomerular structure and function. Anti-VEGF therapy i...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:PLoS One
Huvudupphovsmän: Njau, Florence, Shushakova, Nelli, Schenk, Heiko, Wulfmeyer, Vera Christine, Bollin, Robin, Menne, Jan, Haller, Hermann
Materialtyp: Artigo
Språk:Inglês
Publicerad: Public Library of Science 2020
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6959593/
https://ncbi.nlm.nih.gov/pubmed/31935212
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0218494
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk